Zacks Investment Research highlights Labcorp (LH) as a potentially undervalued stock, currently holding a Zacks Rank #2 (Buy) and a Value grade of A. The analysis points to favorable valuation metrics, including a P/E ratio of 14.56 compared to the industry average of 16.41, a PEG ratio of 1.48 versus the industry's 1.76, and a P/B ratio of 2.44, lower than the industry average of 4.40, suggesting the stock may be attractively priced relative to its earnings outlook and book value.
Labcorp (LH) is presented by Zacks Investment Research as a potentially undervalued stock, currently holding a Zacks Rank #2 (Buy) and a distinguished 'A' grade for Value. This assessment is supported by several key valuation metrics that compare favorably against its industry peers. Specifically, Labcorp's Price-to-Earnings (P/E) ratio stands at 14.56, below the industry average of 16.41; its historical P/E over the past year has ranged from 12.57 to 15.79, with a median of 14.52, indicating its current P/E is near its median. Furthermore, Labcorp's Price/Earnings-to-Growth (PEG) ratio is 1.48, more attractive than the industry average of 1.76; its one-year PEG range was 1.37 to 1.88 with a median of 1.62. The Price-to-Book (P/B) ratio for LH is 2.44, considerably lower than the industry average of 4.40, with a past-year median of 2.38 (range: 2.04-2.67). Lastly, Labcorp's Price-to-Cash Flow (P/CF) ratio is 14.74, compared to an industry average of 17.23, and its median P/CF over the last twelve months was 16.86 (range: 12.90-19.65). Collectively, these metrics, particularly when combined with the positive earnings outlook implied by the Zacks Rank, suggest that Labcorp's stock may be trading at a discount relative to its intrinsic value and future growth prospects.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
